Medical Condition News

RSS

H. pylori infection could play a role in Parkinson's disease development

The stomach bacteria responsible for ulcers could also play a role in the development of Parkinson's disease according to research presented today at the 111th General Meeting of the American Society for Microbiology.

23 May 2011

CT scan may help determine early death in individuals with diabetes

New findings out of Wake Forest Baptist Medical Center reveal that a common test may be useful in predicting early death in individuals with diabetes.

23 May 2011

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor, can also suppress aspects of inflammation.

23 May 2011

Scientists invent Monolayer Stress Microscopy to measure physical forces during collective cellular migration

The physical forces that guide how cells migrate-how they manage to get from place to place in a coordinated fashion inside the living body- are poorly understood. Scientists at the Harvard School of Public Health and the Institute for Bioengineering of Catalonia have, for the first time, devised a way to measure these forces during collective cellular migration.

23 May 2011

Patients with chronic heart failure can benefit from telemonitoring

Two trials presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology, will help to define the precise populations of patients with chronic heart failure in whom telemedical management delivers benefits.

23 May 2011

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial.

23 May 2011

New insights into bone diseases

A study by researchers at Children's Hospital Boston and collaborators at other institutions has provided new insights into the means by which bone cells produce new bone in response to mechanical stresses, such as exercise.

23 May 2011

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

The aldosterone antagonist eplerenone significantly reduced the development of new onset atrial fibrillation and flutter in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology.

23 May 2011

Paralyzed man walks again

Three years ago, baseball champion Rob Summers was hit by a speeding car in Portland, Oregon which smashed into his legs and left him with appalling injuries. He was told he would spend the rest of his life in a wheelchair at best. However the 25 year old has become the first person paralyzed from the chest down to stand and take a step unaided.

22 May 2011

UB's graded exercise test for concussion could help decide hockey player's fitness to return to the ice

As the chase for the 2011 Stanley Cup heads to the finish, several players are off the ice suffering from concussion, an injury all too common in this contact sport.

21 May 2011

NIH allocated $400 million funding for pain research in 2010

An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.

21 May 2011

Salk researchers successfully edit diseased gene in patient-specific induced pluripotent stem cells

In principle, genetic engineering is simple, but in practice, replacing a faulty gene with a healthy copy is anything but. Using mutated versions of the lamin A gene as an example to demonstrate the versatility of their virus-based approach, researchers at the Salk Institute for Biological Studies successfully edited a diseased gene in patient-specific induced pluripotent stem cells as well as adult stem cells.

21 May 2011

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.

21 May 2011

Modified cells protect marrow and blood cells from harmful chemotherapy effects in brain tumor patients

Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment.

21 May 2011

Global clinical program demonstrates safety of Medtronic Resolute drug-eluting stent

A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.

From Medtronic 21 May 2011

Wills Eye Institute and Thomas Jefferson University create new vision research center

A new vision research center based in Philadelphia will foster regional, national and global collaborations among a diverse group of exceptional clinicians and researchers working to better diagnose, treat and prevent visual diseases.

21 May 2011

FDA approves SUTENT for treatment of pancreatic NET

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pancreatic neuroendocrine tumors (NET) in patients with unresectable locally advanced or metastatic disease. Pancreatic NET is a rare cancer reported in two to four people per million annually worldwide.

21 May 2011

Electrical experiment helps paralyzed man stand, walk

An electrode experiment has helped a paralyzed man stand and walk for short periods, which has some calling it a major breakthrough in treating paralysis. In other news, Ford is developing health-monitoring technology for cars.

21 May 2011

Medicine, osteopathy, physical therapy and chiropractic colleges collaborate to study safety in spinal manipulation

A recent team grant by the Canadian Institute for Health Research is providing an innovative approach to researching patient safety for those who provide and receive spinal-manipulative therapy. The $2-million grant over five years brings together health researchers from across Canada and will involve input from four regulatory colleges in Alberta.

21 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

Medical Condition News

H. pylori infection could play a role in Parkinson's disease development

CT scan may help determine early death in individuals with diabetes

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Scientists invent Monolayer Stress Microscopy to measure physical forces during collective cellular migration

Patients with chronic heart failure can benefit from telemonitoring

Patients with mild heart failure more likely to benefit from cardiac resynchronization therapy with defibrillation

New insights into bone diseases

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

Paralyzed man walks again

UB's graded exercise test for concussion could help decide hockey player's fitness to return to the ice

NIH allocated $400 million funding for pain research in 2010

Salk researchers successfully edit diseased gene in patient-specific induced pluripotent stem cells

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Modified cells protect marrow and blood cells from harmful chemotherapy effects in brain tumor patients

Global clinical program demonstrates safety of Medtronic Resolute drug-eluting stent

Wills Eye Institute and Thomas Jefferson University create new vision research center

FDA approves SUTENT for treatment of pancreatic NET

Electrical experiment helps paralyzed man stand, walk

Medicine, osteopathy, physical therapy and chiropractic colleges collaborate to study safety in spinal manipulation

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News